68 results on '"Pfisterer, Matthias"'
Search Results
2. Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction?
3. Prasugrel vs. clopidogrel in contemporary Western European patients with acute coronary syndromes receiving drug-eluting stents: Comparative cost-effectiveness analysis from the BASKET-PROVE cohorts
4. Predictors and prognostic impact of silent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus
5. Prognostic Usefulness of Cardiac Stress Test Modalities in Patients With Type 2 Diabetes Mellitus Who Underwent Myocardial Perfusion Scintigraphy (from the Basel Asymptomatic High-Risk Diabetics' Outcome Trial)
6. Quality of life as predictor for the development of cardiac ischemia in high-risk asymptomatic diabetic patients
7. Predicting hospitalization and mortality in patients with heart failure: The BARDICHE-index
8. Frequency of Cardiac Death and Stent Thrombosis in Patients With Chronic Obstructive Pulmonary Disease Undergoing Percutaneous Coronary Intervention (from the BASKET-PROVE I and II Trials)
9. Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter study
10. Improvement in left ventricular ejection fraction and reverse remodeling in elderly heart failure patients on intense NT-proBNP-guided therapy
11. Differential Prognostic Impact of Resting Heart Rate in Older Compared With Younger Patients With Chronic Heart Failure—Insights From TIME-CHF
12. Prognostic Value of “Routine” Cardiac Stress Imaging 5 Years After Percutaneous Coronary Intervention: The Prospective Long-Term Observational BASKET (Basel Stent Kosteneffektivitäts Trial) LATE IMAGING Study
13. Interaction Between Pulmonary Hypertension and Diastolic Dysfunction in an Elderly Heart Failure Population
14. Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes — results from the BASKET PROVE trial
15. Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease
16. Frequency and Predictors of Hyperkalemia in Patients ≥60 Years of Age With Heart Failure Undergoing Intense Medical Therapy
17. Management of stable coronary artery disease
18. Predictors of early readmission or death in elderly patients with heart failure
19. Comparison of Six-Month Outcomes for Primary Percutaneous Revascularization for Acute Myocardial Infarction With Drug-Eluting Versus Bare Metal Stents (from the APEX-AMI Study)
20. Percutaneous coronary intervention in the Occluded Artery Trial: Procedural success, hazard, and outcomes over 5 years
21. Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina—Comparison of the effects of drug-eluting versus bare-metal stents
22. Sudden Cardiac Death in Patients With Silent Myocardial Ischemia After Myocardial Infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II])
23. Use of B-type natriuretic peptide outside of the emergency department
24. Outpatient Rehabilitation in Patients With Coronary Artery and Peripheral Arterial Occlusive Disease
25. Hemodynamic Parameters Are Prognostically Important in Cardiogenic Shock But Similar Following Early Revascularization or Initial Medical Stabilization: A Report From the SHOCK Trial
26. A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease
27. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
28. Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month analysis
29. Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: Insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials
30. Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents: An Observational Study of Drug-Eluting Versus Bare-Metal Stents
31. Usefulness of B-Type Natriuretic Peptide and C-Reactive Protein in Predicting the Presence or Absence of Left Ventricular Hypertrophy in Patients With Systemic Hypertension
32. Long-term prognostic value of the preoperative 12-lead electrocardiogram before major noncardiac surgery in coronary artery disease
33. Anemia as independent predictor of major events in elderly patients with chronic angina
34. Use of B-type natriuretic peptide in the detection of myocardial ischemia
35. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET)
36. Influence of Revascularization on Long-Term Outcome in Patients ≥75 Years of Age With Diabetes Mellitus and Angina Pectoris
37. Evidence for left ventricular remodeling after percutaneous coronary intervention: Effect of percutaneous coronary intervention on left ventricular ejection fraction and volumes
38. Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes
39. Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease
40. Bedside quantification of atherosclerosis severity for cardiovascular risk stratification: a prospective cohort study
41. Long-term outcome of angioplasty for multivessel coronary disease: importance and price of complete revascularization
42. Regional Wall Motion Assessment in Stress Echocardiography by Tissue Doppler Bull’s-Eyes
43. Cardiogenic shock complicating acute myocardial infarction: Predictors of death
44. A new memetic pattern based algorithm to diagnose/exclude coronary artery disease
45. Drug-eluting stents and glycoprotein IIb/IIIa inhibitors in vessels at low anatomic risk: A retrospective analysis of previously published data from the Basel Stent Kosten Effektivitäts Trial
46. Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: Study protocol and design
47. Paclitaxel-eluting stents appear to reduce revascularisation in people with long lesions
48. Management of elderly patients with congestive heart failure—Design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)
49. Limited Usefulness of the Modified Academic Research Consortium Stent Thrombosis Definition for Clinical Trials
50. Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.